PURPOSE: Cerebral tissue oxygenation (PbrO(2)) is most frequently monitored using a Licox CC1.SB system (LX, Integra Neuroscience, France) but recently a new probe--the Neurovent-PTO (NV)--was introduced by a different manufacturer (Raumedic, Germany). There are no prospective data on how these probes compare in clinical routine. We therefore compared both probes in comatose patients suffering from traumatic brain injury (TBI) or subarachnoid haemorrhage (SAH) during dynamic changes of inspirational oxygen fraction (FiO(2)) and mean arterial pressure (MAP). METHODS: PbrO(2) in 11 patients was recorded continuously using an LX and NV probe placed side by side into the same cerebrovascular region. Once a steady baseline value was reached FiO(2) was increased by 20% for 10 min. Once the baseline values were re-established MAP was increased by 20 mmHg for 10 min. Evaluation was performed using a four-parameter logistic function and Bland-Altman analyses. RESULTS: PbrO(2) values of both probes differed significantly at all times. The LX probe reacted significantly faster to changes in FiO(2) and MAP. Limits of agreement ranged between -32.1 and 20.0 mmHg. Mean LX values were 6.1 mmHg lower than NV values. CONCLUSIONS: Since the examined patient cohort was rather small, this study's results are preliminary. However, they suggest that LX and NV probes measure different PbrO(2) values in routine monitoring as well as during phases of dynamic changes in FiO(2) and MAP. These data therefore do not support the view that both probes can be used interchangeably.
PURPOSE: Cerebral tissue oxygenation (PbrO(2)) is most frequently monitored using a Licox CC1.SB system (LX, Integra Neuroscience, France) but recently a new probe--the Neurovent-PTO (NV)--was introduced by a different manufacturer (Raumedic, Germany). There are no prospective data on how these probes compare in clinical routine. We therefore compared both probes in comatosepatients suffering from traumatic brain injury (TBI) or subarachnoid haemorrhage (SAH) during dynamic changes of inspirational oxygen fraction (FiO(2)) and mean arterial pressure (MAP). METHODS: PbrO(2) in 11 patients was recorded continuously using an LX and NV probe placed side by side into the same cerebrovascular region. Once a steady baseline value was reached FiO(2) was increased by 20% for 10 min. Once the baseline values were re-established MAP was increased by 20 mmHg for 10 min. Evaluation was performed using a four-parameter logistic function and Bland-Altman analyses. RESULTS: PbrO(2) values of both probes differed significantly at all times. The LX probe reacted significantly faster to changes in FiO(2) and MAP. Limits of agreement ranged between -32.1 and 20.0 mmHg. Mean LX values were 6.1 mmHg lower than NV values. CONCLUSIONS: Since the examined patient cohort was rather small, this study's results are preliminary. However, they suggest that LX and NV probes measure different PbrO(2) values in routine monitoring as well as during phases of dynamic changes in FiO(2) and MAP. These data therefore do not support the view that both probes can be used interchangeably.
Authors: Berk Orakcioglu; Oliver W Sakowitz; Jan-Oliver Neumann; Modar M Kentar; Andreas Unterberg; Karl L Kiening Journal: Neurosurgery Date: 2010-12 Impact factor: 4.654
Authors: Danila K Radolovich; Marek Czosnyka; Ivan Timofeev; Andrea Lavinio; Peter Hutchinson; Arun Gupta; John D Pickard; Peter Smielewski Journal: Neurocrit Care Date: 2009-01-30 Impact factor: 3.210
Authors: Dennis J Nieuwkamp; Larissa E Setz; Ale Algra; Francisca H H Linn; Nicolien K de Rooij; Gabriël J E Rinkel Journal: Lancet Neurol Date: 2009-06-06 Impact factor: 44.182
Authors: Luis Rafael Moscote-Salazar; Andres M Rubiano; Hernando Raphael Alvis-Miranda; Willem Calderon-Miranda; Gabriel Alcala-Cerra; Marco Antonio Blancas Rivera; Amit Agrawal Journal: Bull Emerg Trauma Date: 2016-01
Authors: Joseph C Walsh; Artem Lebedev; Edward Aten; Kathleen Madsen; Liane Marciano; Hartmuth C Kolb Journal: Antioxid Redox Signal Date: 2014-05-09 Impact factor: 8.401
Authors: Massimo Antonelli; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; J Randall Curtis; Daniel De Backer; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Patricia Rocco; Jean-François Timsit; Jan Wernerman; Haibo Zhang Journal: Intensive Care Med Date: 2012-01-04 Impact factor: 17.440
Authors: Walid Albanna; Catharina Conzen; Miriam Weiss; Hans Clusmann; Matthias Fuest; Marguerite Mueller; Marc Alexander Brockmann; Walthard Vilser; Arno Schmidt-Trucksäss; Anke Hoellig; Marcel Seiz; Claudius Thomé; Konstantin Kotliar; Gerrit Alexander Schubert Journal: PLoS One Date: 2016-07-07 Impact factor: 3.240
Authors: Nudrat Tasneem; Edgar A Samaniego; Connie Pieper; Enrique C Leira; Harold P Adams; David Hasan; Santiago Ortega-Gutierrez Journal: Crit Care Res Pract Date: 2017-05-07
Authors: Marius M Mader; Anna Leidorf; Andreas Hecker; Axel Heimann; Petra S M Mayr; Oliver Kempski; Beat Alessandri; Gabriele Wöbker Journal: Neurocrit Care Date: 2018-10 Impact factor: 3.210